arrow
M

Mario Varasi

Ain Shams University
H指数:37
被引数:4,347

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4

基于结构的HECT连接酶NEDD4的高效且选择性抑制剂的构效关系设计

2025-05-280
OA
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
2024-01-272
OAAI
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells
2023-02-019
OAAI
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response
2021-12-0829
OA
High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons

高通量筛选鉴定调节7 q11.23微重复自闭症谱系障碍患者衍生的皮质神经元中GTF2I表达的组蛋白去乙酰化酶抑制剂

2020-11-1921
OAAI
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
2020-02-1421
OAAI
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models
2020-02-1322
OAAI
New 6-and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors
2018-05-0133
OAAI
3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin
2017-05-018
OAAI
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship
2017-02-2764
PREAI
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration
2017-02-2768
PREAI